NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Phosphodiesterase


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


 Refine Search
Display Mode: Context | Summary
Data on enzyme research detailed by researchers at Vanderbilt University
2009 NOV 16 ... "Poor understanding of the topography of cyclic nucleotide (CN) phosphodiesterase (PDE) catalytic sites compromises development of potent, selective inhibitors for ...
Subject: Enzyme Research
Price: $3.00
*
Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
2009 NOV 16 ... the safety and efficacy of udenafil, an orally administered selective inhibitor of phosphodiesterase versus placebo. The trials will be conducted in 80 sites in the U.S. and will enroll ...
Subject: Erectile Dysfunction
Price: $3.00
*
FDA Warns Consumers on Sexual Enhancement Products
2009 NOV 16 ... Keywords: , U.S. Food and Drug Administration, FDA, Regulatory Actions, Sildenafil, Phosphodiesterase Inhibitor, Vasodilator Agent, Sildenafil Citrate, Viagra, Pharmaceuticals, Drugs, ...
Subject: U.S. Food and Drug Administration
Price: $3.00
*
Findings in sleep deprivation reported from University of Pennsylvania
2009 NOV 16 ... mouse hippocampus, reduced cAMP signalling, and increased activity and protein levels of phosphodiesterase 4 (PDE4), an enzyme that degrades cAMP. Treatment of mice with...
Subject: Sleep Deprivation
Price: $3.00
*
Investigators at Kanazawa University publish new data on osteosarcoma
2009 NOV 16 ... System Stimulant, Chemotherapy, Drug Therapy, Oncology, Orthopedics, Osteosarcoma, Phosphodiesterase Inhibitor, Pulmonology, Sarcoma, Soft Tissue Sarcoma, Therapy, Treatment, Kanazawa ...
Subject: Osteosarcoma
Price: $3.00
*
New blood pressure study findings have been published by scientists at Skidmore College
2009 NOV 16 ... Caffeine, Cardiology, Cardiovascular, Central Nervous System Stimulant, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Skidmore College. This article was prepared ...
Subject: Blood Pressure
Price: $3.00
*
New DNA research study results from Shanghai Institute of Materia Medica, Research Division described
2009 NOV 23 ... Genetics, Genomics, Neoplasia, Neurology, Oncology, Pharmaceuticals, Pharmacological, Phosphodiesterase Inhibitor, Proteomics, Topoisomerase, Treatment. This article was prepared ...
Subject: DNA Research
Price: $3.00
*
New findings from University of Cambridge in the area of pharmaceuticals described
2009 NOV 16 ... Drugs, Experimental Pharmacology, Pharmaceuticals, Pharmacological, Pharmacology, Phosphodiesterase Inhibitor, Physiology, Therapy, Treatment. This article was prepared by ...
Subject: Pharmaceuticals
Price: $3.00
*
New hypertension study findings have been published by M. Samarzija and colleagues
2009 NOV 23 ... Zagreb, Croatia. Keywords: City:Zagreb, Country:Croatia, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Vasodilator Agent. This article was prepared by ...
Subject: Hypertension
Price: $3.00
*
New life sciences study findings have been reported from Harvard University, Medical Department
2009 NOV 23 ... Health Policy, Erectile Dysfunction, Impotence, Regulatory Actions, Sildenafil, Phosphodiesterase Inhibitor, Vasodilator Agent, Public Health, Harvard University, Medical Department. ...
Subject: Life Sciences
Price: $3.00
*
Reports from Seoul National University highlight recent research in pharmacology and toxicology
2009 NOV 10 ... Alternative Medicine, Caffeine, Anorexigenic Agent, Central Nervous System Stimulant, Phosphodiesterase Inhibitor, Dextromethorphan, Analgesic, Antitussive, Excitatory Amino Acid Antagonist, ...
Subject: Pharmacology and Toxicology
Price: $3.00
*
Research from University of London, Imperial College in the area of pulmonary hypertension published
2009 NOV 23 ... therapy." "We investigated the effects of combining simvastatin with a phosphodiesterase type-5 inhibitor, sildenafil, in the rat model of hypoxia-induced pulmonary ...
Subject: Pulmonary Hypertension
Price: $3.00
*
Research in the area of sclerosis reported from University of Michigan
2009 NOV 23 ... tolerability, and efficacy of tadalafil, a selective, long acting, type V cyclic GMP phosphodiesterase (PDE-5) inhibitor, in this clinical syndrome," scientists writing in the Journal of ...
Subject: Sclerosis
Price: $3.00
*
Research reports on enzyme research from D.T. Stephenson and colleagues provide new insights
2009 NOV 23 ... in the Journal of Histochemistry & Cytochemistry (Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species. Journal of Histochemistry & Cytochemistry, ...
Subject: Enzyme Research
Price: $3.00
*
Researchers from Johns Hopkins University detail new studies and findings in the area of cell biology
2009 NOV 10 ... of spinal motor neuron differentiation through extracellular glycerophosphodiester phosphodiesterase metabolism. Although this process is likely to be tightly regulated, the relevant ...
Subject: Cell Biology
Price: $3.00
*
Studies from A. Talwar et al add new findings in the area of virology
2009 NOV 23 ... for diagnosis. New therapies like prostanoids, endothelin receptor antagonists, and phosphodiesterase inhibitors have improved the outcome of patients with HIV-associated PAH," wrote A. ...
Subject: Virology
Price: $3.00
*
Study results from Hokkaido University update understanding of glycogen storage disease
2009 NOV 16 ... Japan. Keywords: Japan, Sapporo, Glycogen Storage Disease, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Syncope, Vasodilator Agent, Hokkaido University. ...
Subject: Glycogen Storage Disease
Price: $3.00
*
Study results from Northumbria University provide new insights into hypoglycemia
2009 NOV 16 ... Physiology, Caffeine, Central Nervous System Stimulant, Hypoglycemia, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Northumbria University. This article was ...
Subject: Hypoglycemia
Price: $3.00
*
Teeth Grinding Linked to Sleep Apnea
2009 NOV 16 ... Reflux, Gastrointestinal Reflux Disease, Obstructive Sleep Apnea, Otolaryngology, Phosphodiesterase Inhibitor, Pulmonology, Sleep Disorders, Snoring, TMJ, Temporomandibular Joint ...
Subject: Gastrointestinal Reflux Disease
Price: $3.00
*
Tongji University details research in hypertension
2009 NOV 16 ... Keywords: People's Republic of China, Shanghai, Cardiology, Enzymes, Hypertension, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil, Vasodilator Agent, Tongji University. ...
Subject: Hypertension
Price: $3.00
*

Results 1 - 20      Next >

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login